CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database.
Alcock BP, Raphenya AR, Lau TTY, Tsang KK, Bouchard M, Edalatmand A, Huynh W, Nguyen AV, Cheng AA, Liu S, Min SY, Miroshnichenko A, Tran HK, Werfalli RE, Nasir JA, Oloni M, Speicher DJ, Florescu A, Singh B, Faltyn M, Hernandez-Koutoucheva A, Sharma AN, Bordeleau E, Pawlowski AC, Zubyk HL, Dooley D, Griffiths E, Maguire F, Winsor GL, Beiko RG, Brinkman FSL, Hsiao WWL, Domselaar GV, McArthur AG. · 2020
Read CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. by Alcock BP, Raphenya AR, Lau TTY, Tsang KK, Bouchard M, Edalatmand A, Huynh W, Nguyen AV, Cheng AA, Liu S, Min SY, Miroshnichenko A, Tran HK, Werfalli RE, Nasir JA, Oloni M, Speicher DJ, Florescu A, Singh B, Faltyn M, Hernandez-Koutoucheva A, Sharma AN, Bordeleau E, Pawlowski AC, Zubyk HL, Dooley D, Griffiths E, Maguire F, Winsor GL, Beiko RG, Brinkman FSL, Hsiao WWL, Domselaar GV, McArthur AG. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7145624.txt.
Introduction
Alcock and co-authors describe the 2020 update of CARD, a database of antibiotic resistance in bacteria, in Nucleic Acids Research. CARD holds reference DNA and protein sequences. It also holds models that detect resistance genes in new samples, plus software to run those checks. A shared set of terms keeps the data in order.
Since 2017 the team has added over 500 new detection models. They also revised how entries are sorted and built a new module on resistomes and variants. That module sums up predicted resistance from 82 pathogens and over 100,000 genomes. The sums expose trends in how resistance spreads between bacteria and between places. New tools let outside experts help curate the data, so the reference set stays current as new resistance genes are found.
Catalog record
| CREATOR | Alcock BP, Raphenya AR, Lau TTY, Tsang KK, Bouchard M, Edalatmand A, Huynh W, Nguyen AV, Cheng AA, Liu S, Min SY, Miroshnichenko A, Tran HK, Werfalli RE, Nasir JA, Oloni M, Speicher DJ, Florescu A, Singh B, Faltyn M, Hernandez-Koutoucheva A, Sharma AN, Bordeleau E, Pawlowski AC, Zubyk HL, Dooley D, Griffiths E, Maguire F, Winsor GL, Beiko RG, Brinkman FSL, Hsiao WWL, Domselaar GV, McArthur AG. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database By Brian P Alcock, Amogelang R Raphenya, Tammy T Y Lau, Kara K Tsang, Mégane Bouchard, Arman Edalatmand, William Huynh, Anna-Lisa V Nguyen, Annie A Cheng, Sihan Liu, Sally Y Min, Anatoly Miroshnichenko Published in: Nucleic Acids Research DOI: 10.1093/nar/gkz935 ABSTRACT Abstract The Comprehensive Antibiotic Resistance Database (CARD; https://card.mcmaster.ca) is a curated resource providing reference DNA and protein sequences, detection models and bioinformatics tools on the molecular basis of bacterial antimicrobial resistance (AMR). CARD focuses on providing high-quality reference data and molecular sequences within a controlled vocabulary, the Antibiotic Resistance Ontology (ARO), designed by the CARD biocuration team to integrate with software development efforts for resistome analysis and prediction, such as CARD’s Resistance Gene Identifier (RGI) software. Since 2017, CARD has expanded through extensive curation of reference sequences, revision of the ontological structure, curation of over 500 new AMR detection models, development of a new classification paradigm and expansion of analytical tools. Most notably, a new Resistomes & Variants module provides analysis and statistical summary of in silico predicted resistance variants from 82 pathogens and over 100 000 genomes. By adding these resistance variants to CARD, we are able to summarize predicted resistance using the information included in CARD, identify trends in AMR mobility and determine previously undescribed and novel resistance variants. Here, we describe updates and recent expansions to CARD and its biocuration process, including new resources for community biocuration of AMR molecular reference data. INTRODUCTION In the century since Alexander Fleming isolated penicillin (1,2) and later warned about antibiotic resistance (3), the world of clinical therapeutics has been transformed by antibiotic discovery and their widespread use (4). However, antibiotic misuse and poor stewardship have turned antimicrobial resistance (AMR) into a global health crisis, exacerbated by a withered antibiotic discovery pipeline (5). This has spurred a collaborative global effort to combat AMR, improve antimicrobial stewardship, and advance surveillance of resistance determinants (6–9). With the increasing use of genome sequencing as a surveillance tool for AMR molecular epidemiology (10,11), as well as the targeting of specific AMR genes by novel adjuvants (12), databases and clear nomenclature for AMR gene families is critical. Given the severity of the AMR crisis and the next-generation sequencing revolution, it is no surprise that there is a large diversity of AMR databases and software tools available (10,13). Many of these are highly focused on, for example, metagenomics of environmental AMR (14), profiling for AMR conferring mutations in Mycobacterium tuberculosis (15) or collation of AMR-associated transposable elements (16). Others re-package the content of other AMR databases to provide an alternative database (17), tool (18) or statistical model (19). A small number are primary AMR databases that curate information from the scientific literature into their database to support sequence analysis and knowledge integration. Most notable of these primary AMR databases are ARG-ANNOT (20), ResFinder (21) and increasingly the National Center for Biotechnology Information (NCBI) Pathogen Detection Reference Gene catalog (22). We previously introduced the Comprehensive Antibiotic Resistance Database (CARD; card.mcmaster.ca; (23,24)), a primary bacterial AMR knowledge resource and database which provides genotype analysis and phenotype prediction from curated publications and sequences. In our 2017 update (24), we detailed the reorganization of CARD around a new Model Ontology, which allowed AMR sequence and mutation reference data to be organized by the underlying specific mechanisms of resistance, with subsequent improvements in CARD’s Resistance Gene Identifier (RGI) algorithms. We here describe (i) the expanded biocuration of reference sequences and mutation data in CARD, (ii) expansion of CARD’s Antibiotic Resistance Ontology (ARO) to include terms for harmonization of AMR phenotypic assays, (iii) in silico surveillance of pathogen resistomes and sequence variants, (iv) new tools for classification of reference data and genome annotation results and (v) new efforts toward community biocuration of AMR molecular reference data. EXPANSION OF CARD Current state of CARD and the ARO CARD integrates molecular biology, biochemistry and bioinformatics within an ontological framework to produce a database that is both functional and practical for clinicians, researchers, industry and public health agencies. The primary objective of CARD is to harmonize and standardize, through expert human curation, AMR molecular sequence knowledge to produce a reliable and trustworthy central database of sequences and mutations known to confer AMR. All curated data within CARD are organized using controlled vocabularies (i.e. ontologies), with four such ontologies being central to its operation: the ARO, the CARD Model Ontology (MO), the CARD Relations Ontology (RO; an augmented subset of the Open Biological and Biomedical Ontology (OBO) Relations Ontology) (http://purl.obolibrary.org/obo/ro) and NCBITaxon (a curated subset of the NCBI Organismal Taxonomy Ontology (22)) (http://purl.obolibrary.org/obo/ncbitaxon). The ARO is the primary ontology in CARD as it includes detailed descriptions of the molecular basis for antibiotic resistance, encompassing known AMR determinants (i.e. acquired resistance genes, resistant mutations of housekeeping genes, efflux overexpression, etc.), drug targets, antibiotic molecules and drug classes, and the molecular mechanisms of resistance. The ARO is organized into three major branches: Determinant of Antibiotic Resistance (ARO:3000000), Antibiotic Molecule (ARO:1000003) and Mechanism of Antibiotic Resistance (ARO:1000002). Each resistance determinant described by the ARO (e.g. an individual β-lactamase) must include an ontological connection to each of these three branches. Additional, minor ARO branches detail other aspects of AMR: Antibiotic Target (ARO:3000708), for describing antibiotic-sensitive wild-type bacterial components; Antibiotic Biosynthesis (ARO:3000082), for describing in vivo antibiotic synthesis by bacterial cells or communities; and, Resistance-Modifying Agents (ARO:0000076), for describing antibiotic adjuvants, inhibitors of resistance enzymes, and antibiotic potentiators which help restore a susceptible phenotype. Since our previous update and in collaboration with the Genomic Epidemiology Ontology (GenEpiO.org), we have added a new AMR Phenotype Terminology branch (ARO:3000045) to the ARO containing 133 terms describing clinical AMR phenotypes, laboratory microbial susceptibility testing and testing reference standards. Overall, each entity in ARO uses semantic relationships within and between these branches to provide the full biochemical context for each AMR determinant, some of which have been updated (Table 1). Additionally, CARD has recently launched draft ontologies for both virulence (VIRO; 701 ontology terms) and mobile genetic elements (MOBIO; 283 ontology terms), which are in active development. [Table: Ontological relationships used by CARD within the Antibiotic Resistance Ontology (ARO)] CARD curation occurs continuously, with monthly updates released by a team of biocurators. CARD curation involves both a descriptive component (i.e. an ontology term) and a functional component (i.e. AMR detection models with associated reference sequences). The curation process primarily involves regular review of the available scientific literature, as described in detail below, to determine applicable additions and modifications. Enforced curation guidelines provide the necessary context to ensure proper hierarchical classification, defined semantic relationships and data standardization. For example, when a new resistance determinant is identified, a biocurator places it within the ARO with the appropriate ontological relationships to indicate the AMR gene family, resistance mechanism and observed drug-class resistance. The biocuration team additionally annotates each ARO term with supplemental information from external references, including relevant publications (via NCBI PubMed (22)), chemical structures (for antibiotics in particular, via NCBI PubChem (25)) or protein structure via the Protein DataBank (rcsb.org; 26)). At last, ARO terms for AMR determinants are paired with an AMR detection model, which includes the nucleotide and peptide sequence retrieved from NCBI GenBank